FEATURED ARTICLES
The Promise Of MRD-Guided CAR-T Treatment
Minimal residual disease markers can reveal relapse before clinical signs appear, when off-the-shelf cell therapy may have its greatest advantage.
-
![Oncolytic Virus immunotherapy and cancer vaccine Therapy-GettyImages-1440747009]( "Immune Priming, Oncolytic Viruses, And The Next Phase Of Solid Tumor Immunotherapy")
Immune Priming, Oncolytic Viruses, And The Next Phase Of Solid Tumor ImmunotherapyCan priming with oncolytic viruses be a better path to reeducating the immune system to recognize and attack cancer? Oncolytics Biotech advisor Richard Vile, Ph.D., says yes.
-
![doctor and female patient review results on a computer monitor-GettyImages-2174584561]( "4 Ways That AI And Point-Of-Care Diagnostics Are Redefining Clinical Trial Design And Operations")
4 Ways That AI And Point-Of-Care Diagnostics Are Redefining Clinical Trial Design And OperationsDiscover how AI-enhanced point-of-care diagnostics are changing trial design and what ClinOps should do next.
-
![samples under microscopes, analyze data-GettyImages-2191794159]( "What BriaCell's Trial Design Says About Real-World Cancer Research")
What BriaCell's Trial Design Says About Real-World Cancer ResearchBriaCell President and CEO William Williams, MD, shares how broader eligibility criteria and physician’s choice controls can better reflect real-world cancer care.
SERVICES & PRODUCTS
Mobile ophthalmic clinical research and clinical trial on-site support services designed to address challenges across all trial phases and ensure reliable protection of ocular endpoints.
Reach critical first-in-human milestones faster with experienced teams, rapid study start-up, and real-time data that reduce complexity, inform decisions, and de-risk development.
Expert Support for Clinical Research and Research Administration
Proof-of-concept provides a critical bridge between Phase 1 and Phase 2 trials, making an experienced CRO partner vital to achieving optimal outcomes for early-phase clinical research.
Ensure accurate, compliant, and impactful documentation with Altasciences' experienced medical writers and regulatory experts.
Design, build, simulate, and analyze clinical studies in one connected system. Embedded intelligence supports the full lifecycle, from protocol development to closeout.